Copanlisib population pharmacokinetics from phase I–III studies and exposure–response relationships in combination with rituximab

por Morcos, Peter N., Moss, Jonathan, Austin, Rupert, Hiemeyer, Florian, Zinzani, Pier Luigi, Beckert, Vita, Mongay Soler, Lidia, Childs, Barrett H., Garmann, Dirk
Publicado 2023